JO
DRUG

John Overdeck’s Bright Minds Biosciences DRUG Stock Holding History

John Overdeck’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$674K Buy
+9,606
New +$754K ﹤0.01% 3922
2026
Q1 		– Sell
-2,601
Closed -$203K – 4659
2025
Q4 		$203K Sell
2,601
-8,110
-76% -$542K ﹤0.01% 3759
2025
Q3 		$650K Buy
+10,711
New +$416K ﹤0.01% 2856
2022
Q4 		– Sell
-2,214
Closed -$14K – 2862
2022
Q3 		$14K Buy
+2,214
New +$14.4K ﹤0.01% 2397

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

John Overdeck's DRUG Position: Q2 2026 in Review

John Overdeck opened a new position in Bright Minds Biosciences (DRUG) in Q2 2026: 9,606 shares worth $674K. The stake represents ﹤0.01% of the portfolio and ranks #3922 among its holdings. This is a return to the name: John Overdeck previously reported a position in DRUG as recently as Q4 2025.

John Overdeck first reported a position in DRUG in Q3 2022 and has held it in 4 quarters since. 99 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • John Overdeck held 9,606 shares of Bright Minds Biosciences worth $674K as of Q2 2026.
  • Bright Minds Biosciences was a new John Overdeck position in Q2 2026.
  • Bright Minds Biosciences made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3922 holding.
  • John Overdeck first reported a position in Bright Minds Biosciences in Q3 2022 and has held it in 4 quarters since.
  • 99 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.